Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bansi

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
International Journal of STD & AIDS|July 5, 2007
Screening for rectal chlamydia infection in a genitourinary medicine clinicD Ivens, K Macdonald, L Bansi, et al.
International Journal of STD & AIDS|February 16, 2008
Prevalence of Chlamydia trachomatis and associated risk factors in women inmates admitted to a youth offenders institute in the UKG Gabriel, T Burns, R Scott-Ram, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|June 22, 2013
Rates of subsequent surgery following endometrial ablation among English women with menorrhagia: population-based cohort studyL Bansi-Matharu, I Gurol-Urganci, T A Mahmood, et al.
International Journal of STD & AIDS|August 12, 2016
Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog StudyT J Barber, L Bansi, A Pozniak, et al.
Journal of Viral Hepatitis|October 21, 2009
The prevalence of hepatitis C virus (HCV) infection in HIV-positive individuals in the UK - trends in HCV testing and the impact of HCV on HIV treatment outcomesJ Turner, L Bansi, R Gilson, et al.
HIV Medicine|November 9, 2010
Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late startersL Waters, M Fisher, J Anderson, et al.
HIV Medicine|November 21, 2008
The associations between age and the development of laboratory abnormalities and treatment discontinuation for reasons other than virological failure in the first year of highly active antiretroviral therapyC A Sabin, C J Smith, V Delpech, et al.
HIV Medicine|February 12, 2010
Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populationsL Bansi, C Sabin, V Delpech, et al.
HIV Medicine|May 15, 2013
Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analoguesM M Santoro, C Sabin, F Forbici, et al.
HIV Medicine|November 24, 2011
Non-uptake of highly active antiretroviral therapy among patients with a CD4 count < 350 cells/μL in the UKC Kober, M Johnson, M Fisher, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
International Journal of STD & AIDS|July 5, 2007
Screening for rectal chlamydia infection in a genitourinary medicine clinicD Ivens, K Macdonald, L Bansi, et al.
International Journal of STD & AIDS|February 16, 2008
Prevalence of Chlamydia trachomatis and associated risk factors in women inmates admitted to a youth offenders institute in the UKG Gabriel, T Burns, R Scott-Ram, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|June 22, 2013
Rates of subsequent surgery following endometrial ablation among English women with menorrhagia: population-based cohort studyL Bansi-Matharu, I Gurol-Urganci, T A Mahmood, et al.
International Journal of STD & AIDS|August 12, 2016
Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog StudyT J Barber, L Bansi, A Pozniak, et al.
Journal of Viral Hepatitis|October 21, 2009
The prevalence of hepatitis C virus (HCV) infection in HIV-positive individuals in the UK - trends in HCV testing and the impact of HCV on HIV treatment outcomesJ Turner, L Bansi, R Gilson, et al.
HIV Medicine|November 9, 2010
Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late startersL Waters, M Fisher, J Anderson, et al.
HIV Medicine|November 21, 2008
The associations between age and the development of laboratory abnormalities and treatment discontinuation for reasons other than virological failure in the first year of highly active antiretroviral therapyC A Sabin, C J Smith, V Delpech, et al.
HIV Medicine|February 12, 2010
Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populationsL Bansi, C Sabin, V Delpech, et al.
HIV Medicine|May 15, 2013
Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analoguesM M Santoro, C Sabin, F Forbici, et al.
HIV Medicine|November 24, 2011
Non-uptake of highly active antiretroviral therapy among patients with a CD4 count < 350 cells/μL in the UKC Kober, M Johnson, M Fisher, et al.
Pageof 2